Correction to AstraZeneca Earnings Article
12 Novembro 2021 - 07:07AM
Dow Jones News
AstraZeneca PLC's coronavirus vaccine contributed $0.01 to
earnings per share in the third quarter, though the company lost
$0.03 per share from its development since the start of the year.
"AstraZeneca Swung to 3Q Loss Despite Higher Revenue; Continues to
Lose Money From Covid-19 Vaccine," at 0741 GMT, incorrectly said
that development of the vaccine shaved $0.01 off earnings in the
third quarter.
(END) Dow Jones Newswires
November 12, 2021 04:52 ET (09:52 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
AstraZeneca (NASDAQ:AZN)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
AstraZeneca (NASDAQ:AZN)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024